The Rab-GTPase activating protein TBC1D1 is a paralog of AS160/TBC1D4. AS160/TBC1D4, a downstream effector of Akt, has been shown to play a central role in betacell function and survival. The two proteins have overlapping function in insulin signalling in muscle cells. However, the expression and the potential role of TBC1D1 in beta-cells remain unknown. Therefore, the aim of this study is to investigate whether TBC1D1 is expressed in beta-cells and whether it plays, as AS160/TBC1D4, a role in beta-cell function and survival.
INTRODUCTION
The mechanism and the signalling pathways that regulate insulin secretion and betacell mass represent a critical issue for understanding diabetes mellitus, a disease characterized in its two major forms by a relative or absolute deficiency in the number of pancreatic beta-cells. Studies that involved insulinoma cells and animal models with genetic knockout of the insulin receptor, insulin receptor substrates, and insulin-like growth factor I receptor (IGFIR) provided evidence that insulin/IGFIR/PI3K signalling pathways mediate insulin action in beta-cells (1; 2) . Moreover, these studies demonstrated that activation of the insulin receptor and insulin receptor substrate is required for the glucose effects on beta-cell growth and survival. The complexity of insulin signalling cascades is highlighted by the existence of multiple isoforms of target proteins implicated in metabolic and gene-regulatory events. Rab-GTPase activating protein (Rab-GAP) AS160, also known as TBC1D4, is a major downstream effector of insulin signalling in insulin sensitive tissues (muscle and fat) and is implicated in GLUT4 translocation (3) .
Recently, we showed that AS160/TBC1D4 is expressed and phosphorylated in response to glucose in pancreatic human beta-cells and is involved in glucose stimulated insulin secretion (GSIS), proliferation and survival (4) . This study revealed that AS160/TBC1D4 plays a central role in beta-cell function and survival, in line with previous studies demonstrating that the insulin signalling pathway plays a central role in beta-cells.
TBC1D1, a paralog of TBC1D4, has been shown to be expressed in human skeletal muscle and to be involved in GLUT4 translocation after insulin stimulation or muscle contraction (5) . Moreover, several studies have demonstrated a critical role for TBC1D1 in glucose and lipid metabolism as well as in whole body energy homeostasis (6).
Nevertheless, a genetic variant of TBC1D1 (R125W) is associated with predisposition for human obesity (7) . There is approximately 50% homology between AS160/TBC1D4 and TBC1D1, but the Rab-GAP domains are almost identical, thus implying that the 2 proteins might have some overlapping function (8) . Indeed, It has been shown that in their nonphosphorylated state AS160/TBC1D4 and its paralog TBC1D1 retain GLUT4 in intracellular vesicles by keeping target Rabs in an inactive, GDP-bound state. When TBC1D1/4 Rab-GAP activity is inhibited by phosphorylation, GLUT4 vesicles are released for translocation to the cell surface, leading to increased transport of glucose across the cell membrane (3). In skeletal muscle and adipose tissue, insulin treatment and subsequent AMPK activation induce a specific phosphorylation profile of TBC1D1 (Ser-237 and Thr-596). This phosphorylation profile determines its specific activation (9) . Moreover, the presence only on TBC1D1 and not on TBC1D4 of an AMPK dependent site of phosphorylation (Ser-237 in humans and Ser-231 in rats) contributes in part to explain its unique regulatory properties (10) . We and others have demonstrated in the past that a parallel can be made between the regulation of GLUT4 and insulin granule trafficking (1; 11).
The aim of the present study was to investigate whether TBC1D1 is expressed and phosphorylated in response to glucose in primary human and rat sorted beta-cells and if so to determine its involvement in GSIS as well as in beta-cell proliferation and survival.
METHODS
Islets, primary beta-cell purification and culture Islets of Langerhans were isolated by collagenase digestion of pancreas from adult male Wistar rats. This study was conducted and the animal sacrificed with the authorization from Geneva State Veterinarian's Office.
Beta-cells were separated from non beta-cells by autofluorescence-activated cell sorting (FACS) using a FACSVantage (Becton Dickinson, Franklin Lakes, NJ) as described previously (12) . Sorted rat beta-cells purity was assessed by immunofluorescence staining for insulin. Sorted rat beta-cells were cultured in DMEM medium containing 11 mmol/l glucose, 0.05 mg/ml gentamicin, 100 U/ml penicillin, 100 mg/ml streptomycin, and 10% fetal calf serum (Sigma-Aldrich, St. Louis, MO, USA). Sorted rat beta-cells were cultured on plastic dishes coated with extracellular matrix derived from 804G cells as described elsewhere (12) and beta-cells were sorted by FACS after labelling with Newport Green and exclusion of ductal cells and dead cells using a FACSVantage (Becton Dickinson) as described before (12) . The purity of the beta-cells was performed for each preparation using immunofluorescence staining for insulin and glucagon. Technologies) .
RNA extraction, library preparation, sequencing and read mapping Sorted beta-cells and islets were centrifuged, the supernatant was removed and the pellet disrupted in RLT buffer (RNeasy, Qiagen, Hilden, Germany). Total RNA was prepared according to the standard RNeasy protocol. Total RNA library construction, RNA sequencing and read mapping was performed as described in detail elsewhere (14) .
Expression quantification GENCODE annotation v10 was used to assign filtered reads to their corresponding exons and genes. The gene counts were incremented non-redundantly i.e. reads overlapping two exons are counted once to the total count sum per gene. Resulting raw gene counts were normalized to gene length (sum of exons) and sequencing depth i.e.
RPKM -reads per kilobase per million mapped reads (14).
Western blotting Phosphorylation and expression of TBC1D1, or expression of CDK4, Akt 
RESULTS

TBC1D1 is expressed in pancreatic islets and primary beta-cells and is phosphorylated in response to glucose
TBC1D1 is a paralog of TBC1D4 and like it, is phosphorylated in response to insulin in skeletal muscle and adipocytes (3; 15) . Using RNA sequencing, we report for the first time that TBC1D1 is expressed at the mRNA level in human islets and also in FACS-sorted primary human beta-cells (86.7+/-6.8 % insulin positive cells). With this technique, the number of mRNA copies for each gene was obtained, allowing to directly compare the expression of genes of interest. We observed that the expression of TBC1D1 was lower than AS160/TBC1D4 in human sorted beta-cells but similar for the 2 isoforms in human islets (Fig.   1A ). Moreover, we observed in dispersed human islet cells co-stained for TBC1D1 (red), insulin (green) and glucagon (cyan) that TBC1D1 co-localizes with both glucagon and insulin (Fig. 1B) . These immunofluorescence results confirm that TBC1D1 is expressed at the protein level in both these human islets cell types.
We use a silencing approach in order to study the role of TBC1D1 in beta-cells.
However, in our hands siRNA transfection of human beta-cells is not feasible. Therefore we used primary rat beta-cells for this purpose, having shown previously that siRNA transfection is efficient in these cells (4; 13). We analysed TBC1D1 protein expression and phosphorylation in rat primary sorted beta-cells (over 90% insulin positive cells) by immunofluorescence (Fig. 1C) . We investigated the phosphorylation of 2 key sites on rat TBC1D1: Thr-596 and Ser-231. TBC1D1 Thr-596 is a phosphorylation site identical to Thr-642 on AS160/TBC1D4. We have observed that AS160/TBC1D4 Thr-642 is phosphorylated in response to glucose in beta cells and that this phosphorylation is Akt dependent (unpublished observation). TBC1D1 Ser-231 is the rat phosphorylation site equivalent to human Ser-237, a motif recognized by AMPK that has been shown to be phosphorylated in muscle after exercise and to be involved in Glut4 trafficking (9) . TBC1D1 Ser-231 is phosphorylated in rat beta-cells already after 10 min glucose stimulation ( Fig. 2A ) and this phosphorylation is still present after 60 min glucose stimulation (Fig 1C and 2B) . By contrast, 10 min glucose stimulation is not sufficient to induce TBC1D1 Thr-596 phosphorylation ( Fig.   2C ) whereas this site is phosphorylated after 60 min glucose stimulation ( Fig. 1C and 2D ).
Taken together, these data on TBC1D1 expression and phosphorylation after glucose stimulation suggest that this protein might play a role in beta-cell response to glucose.
Modulation of beta-cell function and proliferation by TBC1D1 silencing
To study the biological function of TBC1D1, primary rat beta-cells were transfected with siRNA against TBC1D1 or scrambled siRNA (control). Cells transfected with TBC1D1
siRNA showed a 70% reduction in TBC1D1 protein expression (Fig. 3A) . In cells with such reduced TBC1D1 expression, basal insulin as well as glucose stimulated insulin secretion were modestly increased without any change in fold-stimulation (Fig. 3B) and total insulin content (data not shown). These results suggest that TBC1D1 is not essential for GSIS in sorted rat primary beta-cells, in marked contrast to our earlier results documenting a direct role of AS160/TBC1D4 in this process (4) . We also stimulated the beta-cells with KCl which induces calcium influx and thereby insulin secretion independently of glucose metabolism.
Knockdown of TBC1D1 totally prevented KCl induced insulin secretion (Fig 3C) .
To investigate the impact of TBC1D1 silencing on rat primary beta-cell apoptosis and proliferation in culture, cell death was quantified using TUNEL assay and cell replication was assessed by BrdU incorporation over 24 h. Knockdown of TBC1D1 did not affect beta-cell death ( Fig. 4A and 4B ). However, proliferation of primary rat beta-cells transfected with TBC1D1 was dramatically decreased when compared to cells transfected with scrambled siRNA (Fig. 4C ). This marked reduction in proliferation when TBC1D1 is knocked down was also observed with elevated glucose concentrations in the rat beta-cell culture media (22mM or 33mM glucose, data not shown). We also investigated the expression of 2 proteins implicated in beta-cell survival and proliferation, Akt and Cdk4; neither was influenced by TBC1D1 knockdown.
DISCUSSION
We have recently demonstrated that TBC1D4/AS160 is expressed in human and rodent pancreatic beta-cells and phosphorylated after glucose stimulation (4). We further established that this protein is involved in glucose induced insulin secretion, proliferation and survival of primary sorted beta-cells (4). TBC1D1 and AS160/TBC1D4 have significant sequence similarity and overlapping function in insulin responsive tissues (8) . Nevertheless, the presence only on TBC1D1 and not on TBC1D4 of an AMPK dependent site of phosphorylation on Ser-231 in the rat protein studied here (corresponding to Ser-237 in the human protein) may contribute towards its unique regulatory properties (10) . In the present study, we reveal for the first time that TBC1D1 is expressed and phosphorylated upon glucose stimulation in human islets, as well as in human and rat isolated beta-cells. Since TBC1D1 is expressed and phosphorylated in response to glucose in rat primary beta-cells, we have used these cells to study the role of TBC1D1 in beta-cell function, proliferation and survival. Several studies have shown that a parallel mechanism could be observed between Glut4 and insulin vesicle trafficking (16) . We report here for the first time that two key TBC1D1 phosphorylation sites, Ser-231 (AMPK dependent) and Thr-596
(probably Akt dependent), are phosphorylated in response to glucose, suggesting that TBC1D1 is implicated in the beta-cell function. However, Ser-231 is phosphorylated already after 10 min glucose stimulation, whereas Thr-596 is only phosphorylated after 1 h of stimulation. The kinetics of phosphorylation of the 2 phospho-specific sites in response to glucose suggests either that TBC1D1 interacts with different kinases or that different stimuli are involved (glucose vs. insulin/IGF2). Our data suggest that AMPK and Akt are involved in the early (Ser-231) and late (Thr-596) glucose-stimulated TBC1D1 phosphorylation events respectively. It is postulated that downstream signalling cascades may impact differently on beta-cell function. These cascades are multiple, complex and overlapping, both in terms of insulin secretion (17) and beta-cell proliferation (18) which make their identification complex.
In insulin target tissues, TBC1D1 and AS160/TBC1D4 phosphorylation inhibits their Rab-GAP activity. Therefore, silencing of TBC1D1 mimics this phosphorylation and inactive status. Knockdown of TBC1D1 mildly affected beta-cell function by increasing to a small and comparable extent both basal and stimulated insulin secretion, while we have shown that AS160/TBC1D4 was a key regulator of insulin secretion (4). This suggests that TBC1D1 might interact with specific Rab proteins distinct from those downstream of TBC1D4.
Moreover, beta-cells with decreased TBC1D1 expression were unable to respond to KCl stimulated insulin secretion. Overall, our results suggest that TBC1D1 gets phosphorylated in response to glucose stimulation in beta-cells without playing a major role in glucose stimulated insulin release. However, it appears essential for calcium mediated insulin release in response to direct depolorization by KCl. The apparent discrepancy between these findings is perhaps explained by the well-documented ability of glucose to elicit insulin secretion through increased cytosolic calcium while also activating a calcium-independent potentiating pathway (19) that would appear not to require TBC1D1. In summary, our data suggest that the 2 paralog proteins, TBC1D1 and 4, have distinct roles in the regulation of insulin secretion; TBC1D1 plays a role in the maintenance of baseline insulin secretion and is essential for calcium-mediated secretion, whereas AS160/TBC1D4 plays a more central role in glucose stimulated insulin secretion.
Decreased protein expression of TBC1D1 inhibited beta-cell proliferation without affecting survival, while AS160/TBC1D4 is involved in both beta-cell survival and proliferation suggesting again that these 2 proteins have non-redundant functions (4). The strong decrease in beta-cell proliferation when TBC1D1 is knocked down seems to be independent of the glucose concentration present in the media, suggesting that TBC1D1 plays a central role in beta-cell proliferation. However, when looking at the expression of proteins involved in beta-cell survival and in the cell cycle, knockdown of TBC1D1 does not influence their expression. Nevertheless, TBC1D1 might interact with protein complexes involved in the regulation of the cell cycle.
In conclusion, this study reports for the first time that TBC1D1, known to be involved in the insulin response in muscle and adipose tissue, is expressed in beta-cells, is phosphorylated in response to glucose and is involved in beta-cell proliferation and insulin release. 
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